Skip to content
Disclosery

Pfizer Inc

Follow

13F filer, CIK 78003, New York, NY

Pfizer Inc reported $170,365,906 across 17 holdings for the quarter ended 2026-06-30, in a 13F-HR filed 2026-08-13. Its ten largest share positions make up 95.78% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000078003-26-000102

Period
2026-06-30
Reported value
$170M
Holdings
17
Top 10 weight
95.78%
New
0
Sold out
1

Largest buys vs the previous quarter

None.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
ORICreduced-4,407,497-$42M
ZURAreduced-2,300,072-$12.3M
QTTBexited-101,618-$737K
NXTCreduced-109,007-$179K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2026

Share positions as resolved from 13F-HR 0000078003-26-000102, largest first. % of portfolio is the value over $170,365,906, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
ALLOALLOGENE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: 22,032,040 shares; 2025Q1: 22,032,040 shares; 2025Q2: 22,032,040 shares; 2025Q3: 22,032,040 shares; 2025Q4: 22,032,040 shares; 2026Q1: 22,032,040 shares; 2026Q2: 22,032,040 shares 22,032,040$46.9M27.55%0Timeline
CELCCELCUITY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: 349,406 shares; 2025Q1: 349,406 shares; 2025Q2: 349,406 shares; 2025Q3: 349,406 shares; 2025Q4: 349,406 shares; 2026Q1: 295,652 shares; 2026Q2: 295,652 shares 295,652$29.6M17.35%0Timeline
ARVNARVINAS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: 3,457,815 shares; 2025Q1: 3,457,815 shares; 2025Q2: 3,457,815 shares; 2025Q3: 3,457,815 shares; 2025Q4: 3,457,815 shares; 2026Q1: 3,457,815 shares; 2026Q2: 3,457,815 shares 3,457,815$27.7M16.24%0Timeline
PYXSPYXIS ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: 7,032,770 shares; 2025Q1: 7,032,770 shares; 2025Q2: 7,032,770 shares; 2025Q3: 7,032,770 shares; 2025Q4: 7,032,770 shares; 2026Q1: 7,032,770 shares; 2026Q2: 7,032,770 shares 7,032,770$19.5M11.43%0Timeline
WVEWAVE LIFE SCIENCES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: 1,875,000 shares; 2025Q1: 1,875,000 shares; 2025Q2: 1,875,000 shares; 2025Q3: 1,875,000 shares; 2025Q4: 1,875,000 shares; 2026Q1: 1,875,000 shares; 2026Q2: 1,875,000 shares 1,875,000$10.9M6.42%0Timeline
BHVNBIOHAVEN LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: 505,645 shares; 2025Q1: 505,645 shares; 2025Q2: 505,645 shares; 2025Q3: 505,645 shares; 2025Q4: 505,645 shares; 2026Q1: 505,645 shares; 2026Q2: 505,645 shares 505,645$8M4.7%0Timeline
CRBUCARIBOU BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: 4,690,431 shares; 2025Q1: 4,690,431 shares; 2025Q2: 4,690,431 shares; 2025Q3: 4,690,431 shares; 2025Q4: 4,690,431 shares; 2026Q1: 4,690,431 shares; 2026Q2: 4,690,431 shares 4,690,431$7.88M4.63%0Timeline
SPROSPERO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: 2,362,348 shares; 2025Q1: 2,362,348 shares; 2025Q2: 2,362,348 shares; 2025Q3: 2,362,348 shares; 2025Q4: 2,362,348 shares; 2026Q1: 2,362,348 shares; 2026Q2: 2,362,348 shares 2,362,348$5.34M3.13%0Timeline
ZNTLZENTALIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: 953,834 shares; 2025Q1: 953,834 shares; 2025Q2: 953,834 shares; 2025Q3: 953,834 shares; 2025Q4: 953,834 shares; 2026Q1: 953,834 shares; 2026Q2: 953,834 shares 953,834$3.85M2.26%0Timeline
ORICORIC PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: 5,376,344 shares; 2025Q1: 5,376,344 shares; 2025Q2: 5,376,344 shares; 2025Q3: 5,376,344 shares; 2025Q4: 5,376,344 shares; 2026Q1: 4,780,401 shares; 2026Q2: 372,904 shares 372,904$3.55M2.09%-4,407,497Timeline
CRDFCARDIFF ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: 2,411,575 shares; 2025Q1: 2,411,575 shares; 2025Q2: 2,411,575 shares; 2025Q3: 2,411,575 shares; 2025Q4: 2,411,575 shares; 2026Q1: 2,411,575 shares; 2026Q2: 2,411,575 shares 2,411,575$3.01M1.77%0Timeline
ZURAZURA BIO LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: 2,970,022 shares; 2025Q1: 2,970,022 shares; 2025Q2: 2,970,022 shares; 2025Q3: 2,970,022 shares; 2025Q4: 2,970,022 shares; 2026Q1: 2,838,913 shares; 2026Q2: 538,841 shares 538,841$2.88M1.69%-2,300,072Timeline
AGMBAGOMAB THERAPEUTICS NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 75,000 shares; 2026Q2: 75,000 shares 75,000$1.04M0.61%0Timeline
BOLTBOLT BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 31,305 shares; 2025Q3: 31,305 shares; 2025Q4: 31,305 shares; 2026Q1: 31,305 shares; 2026Q2: 31,305 shares 31,305$134K0.08%0Timeline
NXTCNEXTCURE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 157,646 shares; 2025Q4: 157,646 shares; 2026Q1: 153,354 shares; 2026Q2: 44,347 shares 44,347$73K0.04%-109,007Timeline
DNAGINKGO BIOWORKS HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: 2,928 shares; 2025Q1: 2,928 shares; 2025Q2: 2,928 shares; 2025Q3: 2,928 shares; 2025Q4: 2,928 shares; 2026Q1: 2,928 shares; 2026Q2: 2,928 shares 2,928$30K0.02%0Timeline
SENSEONICS HLDGS INCSENSEONICS HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: 43,426 shares; 2025Q1: 43,426 shares; 2025Q2: 43,426 shares; 2025Q3: 43,426 shares; 2025Q4: 2,171 shares; 2026Q1: 2,171 shares; 2026Q2: 2,171 shares 2,171$12.4K0.01%0

Sold out in Q2 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
QTTBQ32 BIO INC101,618$737Kshares

How Q2 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000078003-26-000102 base2026-08-13acceptance time not in the bulk data set